Cholesterol Homeostasis and High-Density Lipoprotein Formation in Arterial Smooth Muscle Cells

Trends in Cardiovascular Medicine

Volumn 20, Issue 3, 2010, Pages 96-102

  Allahverdian, Sima ^a   Francis, Gordon A ^a  

^a ST PAUL S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPID;

ARTERY MUSCLE; ARTERY WALL; ATHEROMA; ATHEROSCLEROSIS; CHOLESTEROL METABOLISM; HOMEOSTASIS; HUMAN; INTIMA; MUSCLE CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

ANIMALS; APOLIPOPROTEIN A-I; ARTERIES; ATHEROSCLEROSIS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; CELL TRANSDIFFERENTIATION; CHOLESTEROL; FOAM CELLS; HOMEOSTASIS; HUMANS; LIPOPROTEINS, HDL; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHENOTYPE; RATS;

EID: 78649829335     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2010.09.002     Document Type: Review

References (81)

1. Aiello R.J., Brees D., Bourassa P.A., et al. Increased atherosclerosis in hyperlipidemic mice with inactivation of ABCA1 in macrophages. Arterioscler Thromb Vasc Biol 2002, 22:630-637.
2. Albrecht C., Soumian S., Amey J.S., et al. ABCA1 expression in carotid atherosclerotic plaques. Stroke 2004, 35:2801-2806.
3. Andreeva E.R., Pugach I.M., Orekhov A.N. Subendothelial smooth muscle cells of human aorta express macrophage antigen in situ and in vitro. Atherosclerosis 1997, 135:19-27.
4. Arciniegas E., Ponce L., Hartt Y., et al. Intimal thickening involves transdifferentiation of embryonic endothelial cells. Anat Rec 2000, 258:47-57.
5. Argmann C.A., Sawyez C.G., Li S., et al. Human smooth muscle cell subpopulations differentially accumulate cholesteryl ester when exposed to native and oxidized lipoproteins. Arterioscler Thromb Vasc Biol 2004, 24:1290-1296.
6. Batetta B., Mulas M.F., Petruzzo P., et al. Opposite pattern of MDR1 and caveolin-1 gene expression in human atherosclerotic lesions and proliferating human smooth muscle cells. Cell Mol Life Sci 2001, 58:1113-1120.
7. Bauriedel G., Hutter R., Welsch U., et al. Role of smooth muscle cell death in advanced coronary primary lesions: implications for plaque instability. Cardiovasc Res 1999, 41:480-488.
8. Benditt E.P., Benditt J.M. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Nat Acad Sci U S A 1973, 70:1753-1756.
9. Bochaton-Piallat M.L., Ropraz P., Gabbiani F., Gabbiani G. Phenotypic heterogeneity of rat arterial smooth muscle cell clones. Implications for the development of experimental intimal thickening. Arterioscler Thromb Vasc Biol 1996, 16:815-820.
10. Breslow J.L. Mouse models of atherosclerosis. Science 1996, 272:685-688.
11. Campbell J.H., Popadynec L., Nestel P.J., Campbell G.R. Lipid accumulation in arterial smooth muscle cells. Influence of phenotype. Atherosclerosis 1983, 47:279-295.
12. Caplice N.M., Bunch T.J., Stalboerger P.G., et al. Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation. Proc Nat Acad Sci USA 2003, 100:4754-4759.
13. Chen W., Wang N., Tall A.R. A PEST deletion mutant of ABCA1 shows impaired internalization and defective cholesterol efflux from late endosomes. J Biol Chem 2005, 280:29277-29281.
14. Choi H.Y., Rahmani M., Wong B.W., et al. ATP-binding cassette transporter A1 expression and apolipoprotein A-I binding are impaired in intima-type arterial smooth muscle cells. Circulation 2009, 119:3223-3231.
15. Chroni A., Kan H.Y., Kypreos K.E., et al. Substitutions of glutamate 110 and 111 in the middle helix 4 of human apolipoprotein A-I (apoA-I) by alanine affect the structure and in vitro functions of apoA-I and induce severe hypertriglyceridemia in apoA-I-deficient mice. Biochemistry 2004, 43:10442-10457.
16. Daum U., Leren T.P., Langer C., et al. Multiple dysfunctions of two apolipoprotein A-I variants, apoA-I(R160L)Oslo and apoA-I(P165R), that are associated with hypoalphalipoproteinemia in heterozygous carriers. J Lipid Res 1999, 40:486-494.
17. Dirksen M.T., Van der Wal A.C., Van den Berg F.M., et al. Distribution of inflammatory cells in atherosclerotic plaques relates to the direction of flow. Circulation 1998, 98:2000-2003.
18. Duong P.T., Collins H.L., Nickel M., et al. Characterization of nascent HDL particles and microparticles formed by ABCA1-mediated efflux of cellular lipids to apoA-I. J Lipid Res 2006, 47:832-843.
19. Fielding C.J., Fielding P.E. Intracellular cholesterol transport. J Lipid Res 1997, 38:1503-1521.
20. Fitzgerald M.L., Okuhira K., Short G.F., et al. ATP-binding cassette transporter A1 contains a novel C-terminal VFVNFA motif that is required for its cholesterol efflux and ApoA-I binding activities. J Biol Chem 2004, 279:48477-48485.
21. Forcheron F., Legedz L., Chinetti G., et al. Genes of cholesterol metabolism in human atheroma: overexpression of perilipin and genes promoting cholesterol storage and repression of ABCA1 expression. Arterioscler Thromb Vasc Biol 2005, 25:1711-1717.
22. Francis G.A. The complexity of HDL. Biochim Biophys Acta 2010, 1801:1286--1293.
23. Francis G.A., Knopp R.H., Oram J.F. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier disease. J Clin Invest 1995, 96:78-87.
24. Francis G.A., Mendez A.J., Bierman E.L., Heinecke J.W. Oxidative tyrosylation of high density lipoprotein by peroxidase enhances cholesterol removal from cultured fibroblasts and macrophage foam cells. Proc Natl Acad Sci U S A 1993, 90:6631-6635.
25. Francis G.A., Oram J.F., Heinecke J.W., Bierman E.L. Oxidative tyrosylation of HDL enhances the depletion of cellular cholesteryl esters by a mechanism independent of passive sterol desorption. Biochemistry 1996, 35:15188-15197.
26. Francis G.A., Tsujita M., Terry T.L. Apolipoprotein AI efficiently binds to and mediates cholesterol and phospholipid efflux from human but not rat aortic smooth muscle cells. Biochemistry 1999, 38:16315-16322.
27. Francone O.L., Royer L., Boucher G., et al. Increased cholesterol deposition, expression of scavenger receptors, and response to chemotactic factors in Abca1-deficient macrophages. Arterioscler Thromb Vasc Biol 2005, 25:1198-1205.
28. Frid M.G., Kale V.A., Stenmark K.R. Mature vascular endothelium can give rise to smooth muscle cells via endothelial-mesenchymal transdifferentiation: in vitro analysis. Circ Res 2002, 90:1189-1196.
29. Frontini M.J., O'Neil C., Sawyez C., et al. Lipid incorporation inhibits Src-dependent assembly of fibronectin and type I collagen by vascular smooth muscle cells.[see comment]. Circ Res 2009, 104:832-841.
30. Gong Q., Pitas R.E. Synergistic effects of growth factors on the regulation of smooth muscle cell scavenger receptor activity. J Biol Chem 1995, 270:21672-21678.
31. Haghpassand M., Bourassa P.A., Francone O.L., Aiello R.J. Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels. J Clin Invest 2001, 108:1315-1320.
32. Hakkinen T., Karkola K., Yla-Herttuala S. Macrophages, smooth muscle cells, endothelial cells, and T-cells express CD40 and CD40L in fatty streaks and more advanced human atherosclerotic lesions. Colocalization with epitopes of oxidized low-density lipoprotein, scavenger receptor, and CD16 (Fc gammaRIII). Virchows Archiv 2000, 437:396-405.
33. Hao H., Gabbiani G., Bochaton-Piallat M.L. Arterial smooth muscle cell heterogeneity: implications for atherosclerosis and restenosis development. Arterioscler Thromb Vasc Biol 2003, 23:1510-1520.
34. Hao H., Ropraz P., Verin V., et al. Heterogeneity of smooth muscle cell populations cultured from pig coronary artery. Arterioscler Thromb Vasc Biol 2002, 22:1093-1099.
35. Hassan H.H., Denis M., Lee D.Y., et al. Identification of an ABCA1-dependent phospholipid-rich plasma membrane apolipoprotein A-I binding site for nascent HDL formation: implications for current models of HDL biogenesis. J Lipid Res 2007, 48:2428-2442.
36. Ishibashi S., Goldstein J.L., Brown M.S., et al. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J Clin Invest 1994, 93:1885-1893.
37. Ishii I., Satoh H., Kawachi H., et al. Intimal smooth muscle cells up-regulate beta-very low density lipoprotein-mediated cholesterol accumulation by enhancing beta-very low density lipoprotein uptake and decreasing cholesterol efflux. Biochim Biophys Acta 2002, 1585:30-38.
38. Komaba A., Li Q., Hara H., Yokoyama S. Resistance of smooth muscle cells to assembly of high density lipoproteins with extracellular free apolipoproteins and to reduction of intracellularly accumulated cholesterol. J Biol Chem 1992, 267:17560-17566.
39. Lemire J.M., Covin C.W., White S., et al. Characterization of cloned aortic smooth muscle cells from young rats. Am J Pathol 1994, 144:1068-1081.
40. Li H., Freeman M.W., Libby P. Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines. J Clin Invest 1995, 95:122-133.
41. Li Q., Komaba A., Yokoyama S. Cholesterol is poorly available for free apolipoprotein-mediated cellular lipid efflux from smooth muscle cells. Biochemistry 1993, 32:4597-4603.
42. Li Q., Tsujita M., Yokoyama S. Selective down-regulation by protein kinase C inhibitors of apolipoprotein-mediated cellular cholesterol efflux in macrophages. Biochemistry 1997, 36:12045-12052.
43. Li Q., Yokoyama S. Independent regulation of cholesterol incorporation into free apolipoprotein-mediated cellular lipid efflux in rat vascular smooth muscle cells. J Biol Chem 1995, 270:26216-26223.
44. Li S., Fan Y.S., Chow L.H., et al. Innate diversity of adult human arterial smooth muscle cells: cloning of distinct subtypes from the internal thoracic artery. Circ Res 2001, 89:517-525.
45. Li X., Van Putten V., Zarinetchi F., et al. Suppression of smooth-muscle alpha-actin expression by platelet-derived growth factor in vascular smooth-muscle cells involves Ras and cytosolic phospholipase A2. Biochem J 1997, 327:709-716.
46. Macdonald D.L., Terry T.L., Agellon L.B., et al. Administration of tyrosyl radical-oxidized HDL inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2003, 23:1583-1588.
47. Mietus-Snyder M., Gowri M.S., Pitas R.E. Class A scavenger receptor up-regulation in smooth muscle cells by oxidized low density lipoprotein. Enhancement by calcium flux and concurrent cyclooxygenase-2 up-regulation. J Biol Chem 2000, 275:17661-17670.
48. Miyazaki A., Sakai M., Suginohara Y., et al. Acetylated low density lipoprotein reduces its ligand activity for the scavenger receptor after interaction with reconstituted high density lipoprotein. J Biol Chem 1994, 269:5264-5269.
49. Mosse P.R., Campbell G.R., Wang Z.L., Campbell J.H. Smooth muscle phenotypic expression in human carotid arteries. I. Comparison of cells from diffuse intimal thickenings adjacent to atheromatous plaques with those of the media. Lab Invest 1985, 53:556-562.
50. Nakashima Y., Plump A.S., Raines E.W., et al. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 1994, 14:133-140.
51. Oram J.F., Heinecke J.W. ATP-binding cassette transporter A1: a cell cholesterol exporter that protects against cardiovascular disease. Physiol Rev 2005, 85:1343-1372.
52. Orekhov A.N., Andreeva E.R., Krushinsky A.V., et al. Intimal cells and atherosclerosis. Relationship between the number of intimal cells and major manifestations of atherosclerosis in the human aorta. Am J Pathol 1986, 125:402-415.
53. Pidkovka N.A., Cherepanova O.A., Yoshida T., et al. Oxidized phospholipids induce phenotypic switching of vascular smooth muscle cells in vivo and in vitro. Circ Res 2007, 101:792-801.
54. Piek J.J., van der Wal A.C., Meuwissen M., et al. Plaque inflammation in restenotic coronary lesions of patients with stable or unstable angina. J Am Coll Cardiol 2000, 35:963-967.
55. Reusch P., Wagdy H., Reusch R., et al. Mechanical strain increases smooth muscle and decreases nonmuscle myosin expression in rat vascular smooth muscle cells. Circ Res 1996, 79:1046-1053.
56. Rong J.X., Shapiro M., Trogan E., Fisher E.A. Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading. Proc Nat Acad Sci USA 2003, 100:13531-13536.
57. Ross R. Cell biology of atherosclerosis. Annu Rev Physiol 1995, 57:791-804.
58. Rothblat G.H., de la Llera-Moya M., Atger V., et al. Cell cholesterol efflux: integration of old and new observations provides new insights. J Lipid Res 1999, 40:781-796.
59. Ruan X.Z., Moorhead J.F., Tao J.L., et al. Mechanisms of dysregulation of low-density lipoprotein receptor expression in vascular smooth muscle cells by inflammatory cytokines. Arterioscler Thromb Vasc Biol 2006, 26:1150-1155.
60. Sakr S.W., Williams D.L., Stoudt G.W., et al. Induction of cellular cholesterol efflux to lipid-free apolipoprotein A-I by cAMP. Biochim Biophys Acta 1999, 1438:85-98.
61. Sata M., Saiura A., Kunisato A., et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002, 8:403-409.
62. Savion N., Kotev-Emeth S. Cholesterol efflux from and high-density-lipoproteins binding to cultured bovine vascular endothelial cells are higher than with vascular smooth muscle cells. Eur J Biochem 1989, 183:363-370.
63. Schwartz S.M., deBlois D., O'Brien E.R. The intima. Soil for atherosclerosis and restenosis. Circ Res 1995, 77:445-465.
64. Schwartz S.M., Murry C.E. Proliferation and the monoclonal origins of atherosclerotic lesions. Annu Rev Med 1998, 49:437-460.
65. Scott N.A., Cipolla G.D., Ross C.E., et al. Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation 1996, 93:2178-2187.
66. See R.H., Caday-Malcolm R.A., Singaraja R.R., et al. Protein kinase A site-specific phosphorylation regulates ATP-binding cassette A1 (ABCA1)-mediated phospholipid efflux. J Biol Chem 2002, 277:41835-41842.
67. Shi Y., O'Brien J.E., Fard A., et al. Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation 1996, 94:1655-1664.
68. Soumian S., Gibbs R., Davies A., Albrecht C. mRNA expression of genes involved in lipid efflux and matrix degradation in occlusive and ectatic atherosclerotic disease. J Clin Pathol 2005, 58:1255-1260.
69. Stary H.C., Chandler A.B., Glagov S., et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1994, 89:2462-2478.
70. Su B., Mitra S., Gregg H., et al. Redox regulation of vascular smooth muscle cell differentiation. Circ Res 2001, 89:39-46.
71. Takahashi M., Takahashi S., Suzuki C., et al. Interleukin-1beta attenuates beta-very low-density lipoprotein uptake and its receptor expression in vascular smooth muscle cells. J Mol Cell Cardiol 2005, 38:637-646.
72. Takahashi Y., Smith J.D. Cholesterol efflux to apolipoprotein AI involves endocytosis and resecretion in a calcium-dependent pathway. Proc Natl Acad Sci U S A 1999, 96:11358-11363.
73. Tang C., Vaughan A.M., Anantharamaiah G.M., Oram J.F. Janus kinase 2 modulates the lipid-removing but not protein-stabilizing interactions of amphipathic helices with ABCA1. J Lipid Res 2006, 47:107-114.
74. Tang C., Vaughan A.M., Oram J.F. Janus kinase 2 modulates the apolipoprotein interactions with ABCA1 required for removing cellular cholesterol. J Biol Chem 2004, 279:7622-7628.
75. Van Eck M., Singaraja R.R., Ye D., et al. Macrophage ATP-binding cassette transporter A1 overexpression inhibits atherosclerotic lesion progression in low-density lipoprotein receptor knockout mice. Arterioscler Thromb Vasc Biol 2006, 26:929-934.
76. Vedhachalam C., Ghering A.B., Davidson W.S., et al. ABCA1-induced cell surface binding sites for ApoA-I. Arterioscler Thromb Vasc Biol 2007, 27:1603-1609.
77. Wagsater D., Olofsson P.S., Norgren L., et al. The chemokine and scavenger receptor CXCL16/SR-PSOX is expressed in human vascular smooth muscle cells and is induced by interferon gamma. Biochem Biophys Res Comm 2004, 325:1187-1193.
78. Wang W.Q., Merriam D.L., Moses A.S., Francis G.A. Enhanced cholesterol efflux by tyrosyl radical-oxidized high density lipoprotein is mediated by apolipoprotein AI-AII heterodimers. J Biol Chem 1998, 273:17391-17398.
79. Wolfbauer G., Glick J.M., Minor L.K., Rothblat G.H. Development of the smooth muscle foam cell: uptake of macrophage lipid inclusions. Proc Nat Acad Sci USA 1986, 83:7760-7764.
80. Yu J., Li Y., Li M., et al. Oxidized low density lipoprotein-induced transdifferentiation of bone marrow-derived smooth muscle-like cells into foam-like cells in vitro. Int J Exp Med 2010, 91:24-33.
81. Zingg J.M., Ricciarelli R., Andorno E., Azzi A. Novel 5' exon of scavenger receptor CD36 is expressed in cultured human vascular smooth muscle cells and atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2002, 22:412-417.